ABOS
Acumen Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.12
+7.07%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-183.4%
Return on equity
-90.5%
Return on assets
-118.7%
Return on invested capital
0.00x
Asset turnover
-$91.8M
Cash from operations
$1.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026